Skip to content

Stockholm Myocardial Infarction with Nonobstructive Coronaries Study 3

Stockholm Myocardial Infarction with Nonobstructive Coronaries Study 3 - Pilot Study of Prevalence of Coronary Microvascular Dysfunction in Myocardial Infarction with Nonobstructive Coronary Arteries

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05426408
Acronym
SMINC-3
Enrollment
85
Registered
2022-06-22
Start date
2022-11-01
Completion date
2026-06-30
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction with Nonobstructive Coronary Arteries

Brief summary

The present pilot study will investigate the prevalence of CMD in an unselected cohort of patients with the working diagnosis MINOCA and to study if the diagnostic yield can be improved by adding adenosine to the CMR investigation. Patient will be their own controls.

Interventions

DIAGNOSTIC_TESTCardiac magnetic resonance imaging to study coronary microvascular dysfunction

Myocardial perfusion mapping will be investigated after administration of adenosine

Sponsors

Region Stockholm
CollaboratorOTHER_GOV
Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Masking description

The investigators who will perform the evaluation of the CMR investigations will be blinded to all clinical data.

Intervention model description

Patients will be their own controls

Eligibility

Sex/Gender
ALL
Age
35 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

* a suspected diagnosis of MINOCA or takotsubo syndrome with coronary angiography without diameter stenosis ≥50% * age 35-80 years * reading and writing proficiency in Swedish

Exclusion criteria

* Claustrofobia * Arrythmia and/or pacemaker (atrial fibrillation and AV-block I- III) * Asthma or severe chronic obstructive lung disease * eGFR \< 30 ml/min * spontaneous coronary artery dissection * acute pulmonary embolism * acute myocardial infarction type 2 * cardiomyopathy other than takotsubo syndrome * a previous myocardial infarction due to CAD

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic yieldThrough investigation completion, usually 2 hoursTo increase the diagnostic yield of CMR imaging in MINOCA as a working diagnosis

Secondary

MeasureTime frameDescription
Prevalence of CMD in MINOCAThrough investigation completion, usually 2 hoursTo determine the proportion of patients with the working diagnosis of MINOCA who have CMD.
Prevalence of CMD in different final MINOCA diagnosesThrough investigation completion, usually 2 hoursTo study the proportions of CMD in patients with a CMR imaging diagnosis of myocardial infarction, Takotsubo, respectively myocarditis and compare them with the results from a healthy control group
Angina pectoris3 MonthsTo investigate the occurrence of angina pectoris before inclusion and after 3 months and relate it to CMD

Countries

Sweden

Contacts

Primary ContactPer Tornvall, MD
per.tornvall@ki.se+468616100
Backup ContactPeder Sörensson, MD
perder.sorensson@regionstockholm.se+46812370000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026